BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32588981)

  • 21. Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.
    Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Solomon SD; Dickstein K; Atar D; Agewall S; Girerd N;
    Am Heart J; 2019 Sep; 215():83-90. PubMed ID: 31291604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics of heart failure with recovered ejection fraction].
    Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
    [No Abstract]   [Full Text] [Related]  

  • 23. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of left ventricular ejection fraction with worsening renal function in patients with acute heart failure: insights from the RELAX-AHF-2 study.
    Feng S; Janwanishstaporn S; Teerlink JR; Metra M; Cotter G; Davison B; Felker GM; Filippatos G; Pang P; Ponikowski P; Sama IE; Voors AA; Greenberg B
    Eur J Heart Fail; 2021 Jan; 23(1):58-67. PubMed ID: 32964537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction.
    Chatterjee NA; Moorthy MV; Pester J; Schaecter A; Panicker GK; Narula D; Lee DC; Goldberger JJ; Kadish A; Cook NR; Albert CM;
    JAMA Cardiol; 2018 Jul; 3(7):591-600. PubMed ID: 29801082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40.
    Sherazi S; McNitt S; Choudhary N; Shah AH; Aktas MK; Asgher A; Schwarz KQ; Zareba W
    Cardiol J; 2015; 22(4):382-90. PubMed ID: 25588532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of mortality in patients with heart failure and atrial fibrillation during long-term follow-up.
    Boldt LH; Schwenke C; Parwani AS; Huemer M; Wutzler A; Haverkamp W
    Acta Cardiol; 2011 Dec; 66(6):751-7. PubMed ID: 22299386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis.
    Borovac JA; Novak K; Bozic J; Glavas D
    Heart Vessels; 2019 Feb; 34(2):268-278. PubMed ID: 30159656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential characteristics of acute heart failure in very elderly patients: the prospective RICA study.
    Huerta-Preciado J; Franco J; Formiga F; Iborra PL; Epelde F; Franco ÁG; Ormaechea G; Manzano L; Cepeda-Rodrigo JM; Montero-Pérez-Barquero M;
    Aging Clin Exp Res; 2020 Sep; 32(9):1789-1799. PubMed ID: 31621036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should HFrEF patients with NYHA class II expect benefit from CCM therapy? Results from the MAINTAINED observational study.
    Fastner C; Yuecel G; Hetjens S; Rudic B; Schmiel G; Toepel M; Liebe V; Kruska M; Borggrefe M; Burkhoff D; Akin I; Duerschmied D; Kuschyk J
    Clin Res Cardiol; 2022 Nov; 111(11):1286-1294. PubMed ID: 36056955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy.
    Briongos-Figuero S; Estévez A; Pérez ML; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Muñoz-Aguilera R
    ESC Heart Fail; 2020 Feb; 7(1):279-283. PubMed ID: 31823514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure.
    Passino C; Pingitore A; Landi P; Fontana M; Zyw L; Clerico A; Emdin M; Iervasi G
    J Card Fail; 2009 Feb; 15(1):35-40. PubMed ID: 19181292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
    Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
    Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypocapnia is an independent predictor of in-hospital mortality in acute heart failure.
    Tang WJ; Xie BK; Liang W; Zhou YZ; Kuang WL; Chen F; Wang M; Yu M
    ESC Heart Fail; 2023 Apr; 10(2):1385-1400. PubMed ID: 36747311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania.
    Gyalai-Korpos I; Ancusa O; Dragomir T; Tomescu MC; Marincu I
    Clin Interv Aging; 2015; 10():561-8. PubMed ID: 25792819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes.
    Asano R; Kajimoto K; Oka T; Sugiura R; Okada H; Kamishima K; Hirata T; Sato N;
    Int J Cardiol; 2017 Mar; 230():585-591. PubMed ID: 28057363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.